In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments.
about
Immunocytokines for cancer treatment: past, present and future.Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma.Irradiation enhances dendritic cell potential antitumor activity by inducing tumor cell expressing TNF-α.Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC.Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12-13 May 2017.Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma.Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.Defining the role of the tumor vasculature in antitumor immunity and immunotherapy.Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma.Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation.Tumor-Specific Inhibition of Vaccination by Distant Untreated Tumor Sites
P2860
Q37560208-C0D601FE-8F37-4C3A-B5DC-6A69EFDD267BQ38662422-5AD49E6E-9BCB-4E14-AED7-49C12108F58DQ38716570-AB71C51C-7E1D-4E33-B5B0-9F4B3C106E90Q38818008-A192999B-7244-471F-B609-09BEA00F4805Q38916529-6719AAB6-FA85-4AD9-9F5C-83E39C0DDA61Q42336210-85F56FF4-4998-42D1-B86D-3E5EBCA61CB2Q42682712-A78C224A-CA37-4826-98ED-9A7ED0A10E54Q46091824-96B260D6-7C16-46AC-8DA7-2DABDDB4D579Q46721978-8A5F51E1-50D4-4FDA-BB06-0E16B769CBEAQ49679692-F1BD90EE-1F34-4528-AED9-F96B8105D748Q50147896-A78FB870-66DC-4CDE-B3FB-31D570E0F27CQ55316979-EEE4BBC3-1B94-4940-8989-820F3AA748CFQ56891314-093697FF-EA30-4B1F-966E-7E34D646313C
P2860
In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In Situ Tumor Vaccination by C ...... or Immunocytokine Treatments.
@en
In Situ Tumor Vaccination by C ...... or Immunocytokine Treatments.
@nl
type
label
In Situ Tumor Vaccination by C ...... or Immunocytokine Treatments.
@en
In Situ Tumor Vaccination by C ...... or Immunocytokine Treatments.
@nl
prefLabel
In Situ Tumor Vaccination by C ...... or Immunocytokine Treatments.
@en
In Situ Tumor Vaccination by C ...... or Immunocytokine Treatments.
@nl
P2093
P2860
P1433
P1476
In Situ Tumor Vaccination by C ...... y or Immunocytokine Treatments
@en
P2093
Alan Korman
Alexander L Rakhmilevich
David M Francis
Emily I Guy
Eric A Armstrong
Fariba Navid
Jacquelyn A Hank
Lakeesha L Carmichael
Lauryn R Werner
Monica M Gressett
P2860
P304
P356
10.1158/0008-5472.CAN-15-2644
P407
P577
2016-05-06T00:00:00Z